Brady Patrick Priest Sells 75,000 Shares of Clover Health Investments, Corp. (NASDAQ:CLOV) Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) CEO Brady Patrick Priest sold 75,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $3.68, for a total value of $276,000.00. Following the sale, the chief executive officer now owns 2,418,151 shares of the company’s stock, valued at $8,898,795.68. This represents a 3.01 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Clover Health Investments Stock Performance

Shares of Clover Health Investments stock traded down $0.03 during trading on Friday, reaching $3.64. The company had a trading volume of 6,480,128 shares, compared to its average volume of 6,327,543. The company has a market cap of $1.82 billion, a price-to-earnings ratio of -18.20 and a beta of 2.00. Clover Health Investments, Corp. has a fifty-two week low of $0.61 and a fifty-two week high of $4.87. The firm’s fifty day moving average is $4.08 and its 200-day moving average is $3.62.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CLOV. Jefferies Financial Group Inc. bought a new stake in shares of Clover Health Investments in the 4th quarter valued at approximately $135,000. Mackenzie Financial Corp boosted its holdings in Clover Health Investments by 211.3% in the fourth quarter. Mackenzie Financial Corp now owns 78,193 shares of the company’s stock worth $246,000 after purchasing an additional 53,076 shares during the period. Alpine Global Management LLC bought a new stake in Clover Health Investments during the fourth quarter valued at $226,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Clover Health Investments by 90.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 830,457 shares of the company’s stock valued at $2,616,000 after purchasing an additional 394,881 shares during the last quarter. Finally, Two Sigma Advisers LP acquired a new stake in shares of Clover Health Investments during the fourth quarter worth $78,000. Institutional investors own 19.77% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Canaccord Genuity Group raised their price objective on Clover Health Investments from $4.20 to $4.50 and gave the company a “buy” rating in a research note on Monday. Craig Hallum started coverage on shares of Clover Health Investments in a research report on Tuesday, December 17th. They set a “buy” rating and a $6.00 price target for the company.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.